Copyright Reports & Markets. All rights reserved.

Global Favipiravir Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Favipiravir
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Favipiravir Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Brand Drug
    • 1.3.3 Generic Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Favipiravir Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Influenza Viruses
    • 1.4.3 COVID-19
    • 1.4.4 Others
  • 1.5 Global Favipiravir Market Size & Forecast
    • 1.5.1 Global Favipiravir Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Favipiravir Sales Quantity (2018-2029)
    • 1.5.3 Global Favipiravir Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 ChemRar Group
    • 2.1.1 ChemRar Group Details
    • 2.1.2 ChemRar Group Major Business
    • 2.1.3 ChemRar Group Favipiravir Product and Services
    • 2.1.4 ChemRar Group Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 ChemRar Group Recent Developments/Updates
  • 2.2 Glenmark
    • 2.2.1 Glenmark Details
    • 2.2.2 Glenmark Major Business
    • 2.2.3 Glenmark Favipiravir Product and Services
    • 2.2.4 Glenmark Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Glenmark Recent Developments/Updates
  • 2.3 Fujifilm
    • 2.3.1 Fujifilm Details
    • 2.3.2 Fujifilm Major Business
    • 2.3.3 Fujifilm Favipiravir Product and Services
    • 2.3.4 Fujifilm Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Fujifilm Recent Developments/Updates
  • 2.4 Dr. Reddy
    • 2.4.1 Dr. Reddy Details
    • 2.4.2 Dr. Reddy Major Business
    • 2.4.3 Dr. Reddy Favipiravir Product and Services
    • 2.4.4 Dr. Reddy Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Dr. Reddy Recent Developments/Updates
  • 2.5 R-Pharma
    • 2.5.1 R-Pharma Details
    • 2.5.2 R-Pharma Major Business
    • 2.5.3 R-Pharma Favipiravir Product and Services
    • 2.5.4 R-Pharma Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 R-Pharma Recent Developments/Updates
  • 2.6 Cipla
    • 2.6.1 Cipla Details
    • 2.6.2 Cipla Major Business
    • 2.6.3 Cipla Favipiravir Product and Services
    • 2.6.4 Cipla Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Cipla Recent Developments/Updates
  • 2.7 Lupin
    • 2.7.1 Lupin Details
    • 2.7.2 Lupin Major Business
    • 2.7.3 Lupin Favipiravir Product and Services
    • 2.7.4 Lupin Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Lupin Recent Developments/Updates
  • 2.8 Sun Pharma
    • 2.8.1 Sun Pharma Details
    • 2.8.2 Sun Pharma Major Business
    • 2.8.3 Sun Pharma Favipiravir Product and Services
    • 2.8.4 Sun Pharma Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Sun Pharma Recent Developments/Updates
  • 2.9 Hisun Pharm
    • 2.9.1 Hisun Pharm Details
    • 2.9.2 Hisun Pharm Major Business
    • 2.9.3 Hisun Pharm Favipiravir Product and Services
    • 2.9.4 Hisun Pharm Favipiravir Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Hisun Pharm Recent Developments/Updates

3 Competitive Environment: Favipiravir by Manufacturer

  • 3.1 Global Favipiravir Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Favipiravir Revenue by Manufacturer (2018-2023)
  • 3.3 Global Favipiravir Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Favipiravir by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Favipiravir Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Favipiravir Manufacturer Market Share in 2022
  • 3.5 Favipiravir Market: Overall Company Footprint Analysis
    • 3.5.1 Favipiravir Market: Region Footprint
    • 3.5.2 Favipiravir Market: Company Product Type Footprint
    • 3.5.3 Favipiravir Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Favipiravir Market Size by Region
    • 4.1.1 Global Favipiravir Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Favipiravir Consumption Value by Region (2018-2029)
    • 4.1.3 Global Favipiravir Average Price by Region (2018-2029)
  • 4.2 North America Favipiravir Consumption Value (2018-2029)
  • 4.3 Europe Favipiravir Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Favipiravir Consumption Value (2018-2029)
  • 4.5 South America Favipiravir Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Favipiravir Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Favipiravir Sales Quantity by Type (2018-2029)
  • 5.2 Global Favipiravir Consumption Value by Type (2018-2029)
  • 5.3 Global Favipiravir Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Favipiravir Sales Quantity by Application (2018-2029)
  • 6.2 Global Favipiravir Consumption Value by Application (2018-2029)
  • 6.3 Global Favipiravir Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Favipiravir Sales Quantity by Type (2018-2029)
  • 7.2 North America Favipiravir Sales Quantity by Application (2018-2029)
  • 7.3 North America Favipiravir Market Size by Country
    • 7.3.1 North America Favipiravir Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Favipiravir Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Favipiravir Sales Quantity by Type (2018-2029)
  • 8.2 Europe Favipiravir Sales Quantity by Application (2018-2029)
  • 8.3 Europe Favipiravir Market Size by Country
    • 8.3.1 Europe Favipiravir Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Favipiravir Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Favipiravir Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Favipiravir Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Favipiravir Market Size by Region
    • 9.3.1 Asia-Pacific Favipiravir Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Favipiravir Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Favipiravir Sales Quantity by Type (2018-2029)
  • 10.2 South America Favipiravir Sales Quantity by Application (2018-2029)
  • 10.3 South America Favipiravir Market Size by Country
    • 10.3.1 South America Favipiravir Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Favipiravir Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Favipiravir Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Favipiravir Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Favipiravir Market Size by Country
    • 11.3.1 Middle East & Africa Favipiravir Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Favipiravir Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Favipiravir Market Drivers
  • 12.2 Favipiravir Market Restraints
  • 12.3 Favipiravir Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Favipiravir and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Favipiravir
  • 13.3 Favipiravir Production Process
  • 13.4 Favipiravir Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Favipiravir Typical Distributors
  • 14.3 Favipiravir Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
    According to our (Global Info Research) latest study, the global Favipiravir market size was valued at USD 352.7 million in 2022 and is forecast to a readjusted size of USD 67 million by 2029 with a CAGR of -21.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.
    This report is a detailed and comprehensive analysis for global Favipiravir market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Favipiravir market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Favipiravir market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Favipiravir market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Favipiravir market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Favipiravir
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Favipiravir market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy and R-Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Favipiravir market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Brand Drug
    Generic Drug
    Market segment by Application
    Influenza Viruses
    COVID-19
    Others
    Major players covered
    ChemRar Group
    Glenmark
    Fujifilm
    Dr. Reddy
    R-Pharma
    Cipla
    Lupin
    Sun Pharma
    Hisun Pharm
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Favipiravir product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Favipiravir, with price, sales, revenue and global market share of Favipiravir from 2018 to 2023.
    Chapter 3, the Favipiravir competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Favipiravir breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Favipiravir market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Favipiravir.
    Chapter 14 and 15, to describe Favipiravir sales channel, distributors, customers, research findings and conclusion.

    Buy now